LAUSR

T he coronavirus disease 2019 (COVID-19) pandemic has dramatically affected health care systems and health outcomes around the world. Transplantation has responded with critical changes to the delivery of transplant services for patients awaiting organ transplantation as well as for the larger group of previously transplanted recipients. The complex clinical nature of these patients as well as the complicated infrastructure required to successfully deliver care to these patients has made the vulnerability of transplant systems apparent to all of us who work in this field. The pandemic also has challenged assumptions about how we care for patients with end-stage organ failure, including revisiting answers to basic questions long thought to have been resolved. More than 20 years ago, Wolfe and colleagues published